S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom

Denali Therapeutics (DNLI) News Today

$16.82
-0.52 (-3.00%)
(As of 04/17/2024 ET)
SourceHeadline
marketbeat.com logoDenali Therapeutics Inc. (NASDAQ:DNLI) Director Sells $30,471.14 in Stock
marketbeat.com - April 17 at 6:51 PM
msn.com logoDenali Therapeutics (DNLI) Price Target Decreased by 5.45% to 42.01
msn.com - April 17 at 1:04 PM
marketbeat.com logoDenali Therapeutics Inc. (NASDAQ:DNLI) Shares Bought by Nisa Investment Advisors LLC
marketbeat.com - April 15 at 5:18 AM
MarketBeat logoDenali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $32.00 at UBS Group
americanbankingnews.com - April 10 at 3:54 AM
MarketBeat logoDenali Therapeutics Inc. (NASDAQ:DNLI) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - April 10 at 2:30 AM
marketbeat.com logoDenali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Recommendation of "Buy" from Brokerages
marketbeat.com - April 10 at 2:29 AM
marketbeat.com logoDenali Therapeutics Inc. (NASDAQ:DNLI) Shares Sold by Baillie Gifford & Co.
marketbeat.com - April 9 at 12:12 PM
marketbeat.com logoDenali Therapeutics (NASDAQ:DNLI) Price Target Cut to $32.00 by Analysts at UBS Group
marketbeat.com - April 9 at 12:12 PM
tmcnet.com logoFlagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
tmcnet.com - April 8 at 12:26 PM
insidertrades.com logoDenali Therapeutics Inc. (NASDAQ:DNLI) Director Steve E. Krognes Sells 92,500 Shares
insidertrades.com - April 3 at 4:56 AM
marketbeat.com logoInsider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) Director Sells 92,500 Shares of Stock
marketbeat.com - April 2 at 9:27 PM
marketbeat.com logoVanguard Group Inc. Buys 354,798 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
marketbeat.com - March 31 at 4:07 AM
msn.com logoDenali Therapeutics files to sell 29.29M shares of common stock for holders
msn.com - March 22 at 6:17 PM
finance.yahoo.com logoFurther weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67%
finance.yahoo.com - March 19 at 8:31 AM
marketbeat.com logoZacks Research Comments on Denali Therapeutics Inc.'s FY2026 Earnings (NASDAQ:DNLI)
marketbeat.com - March 19 at 7:30 AM
marketbeat.com logoWellington Management Group LLP Acquires 250,784 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
marketbeat.com - March 17 at 4:47 AM
finance.yahoo.com logoDNLI Apr 2024 12.500 put
finance.yahoo.com - March 17 at 1:23 AM
finance.yahoo.com logoDNLI Apr 2024 10.000 call
finance.yahoo.com - March 16 at 5:20 AM
finance.yahoo.com logoDNLI Apr 2024 17.500 put
finance.yahoo.com - March 16 at 5:20 AM
marketbeat.com logoDenali Therapeutics Inc. (NASDAQ:DNLI) Shares Acquired by Eventide Asset Management LLC
marketbeat.com - March 1 at 9:33 AM
marketbeat.com logoDenali Therapeutics Inc. Expected to Post FY2024 Earnings of ($2.70) Per Share (NASDAQ:DNLI)
marketbeat.com - March 1 at 8:28 AM
markets.businessinsider.com logoStrong Growth and Value Potential Justify Buy Rating for Denali Therapeutics Despite Dilution
markets.businessinsider.com - March 1 at 6:24 AM
markets.businessinsider.com logoGoldman Sachs Maintains Buy Rating for Denali Therapeutics: Here's What You Need To Know
markets.businessinsider.com - February 29 at 12:39 PM
marketbeat.com logoDenali Therapeutics Inc. Forecasted to Post Q3 2024 Earnings of ($0.58) Per Share (NASDAQ:DNLI)
marketbeat.com - February 29 at 8:40 AM
markets.businessinsider.com logoBuy Rating Affirmed on Denali Therapeutics Amid Promising DNL310 Progress and ETV Technology Potential
markets.businessinsider.com - February 29 at 2:38 AM
markets.businessinsider.com logoStrong Buy Rating for Denali Therapeutics: Financial Stability and Promising Clinical Advancements
markets.businessinsider.com - February 28 at 9:37 PM
markets.businessinsider.com logoBuy Rating Affirmed for Denali Therapeutics on Strong Pipeline and Extended Cash Runway
markets.businessinsider.com - February 28 at 4:37 PM
markets.businessinsider.com logo4 Analysts Assess Denali Therapeutics: What You Need To Know
markets.businessinsider.com - February 28 at 4:37 PM
marketwatch.com logoDenali Therapeutics Shares Rise 19% After $500M Financing
marketwatch.com - February 28 at 11:36 AM
marketbeat.com logoDenali Therapeutics (NASDAQ:DNLI) Trading Down 9.2% After Earnings Miss
marketbeat.com - February 28 at 10:47 AM
marketbeat.com logoDenali Therapeutics (NASDAQ:DNLI) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS
marketbeat.com - February 28 at 10:27 AM
marketbeat.com logoDenali Therapeutics (NASDAQ:DNLI) Stock Rating Reaffirmed by Wedbush
marketbeat.com - February 28 at 8:21 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS) and Denali Therapeutics (DNLI)
markets.businessinsider.com - February 27 at 5:40 PM
finanznachrichten.de logoDenali Therapeutics Inc.: Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
finanznachrichten.de - February 27 at 12:40 PM
msn.com logoCalidi Biotherapeutics, Minerva Neurosciences and Janux among healthcare movers
msn.com - February 27 at 12:40 PM
msn.com logoDenali spikes after $500M private placement
msn.com - February 27 at 12:40 PM
finance.yahoo.com logoDenali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results
finance.yahoo.com - February 27 at 12:40 PM
marketbeat.com logoDenali Therapeutics (NASDAQ:DNLI) Shares Gap Up to $16.89
marketbeat.com - February 27 at 11:47 AM
globenewswire.com logoDenali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
globenewswire.com - February 27 at 8:05 AM
globenewswire.com logoDenali Therapeutics Announces $500 million Private Placement Equity Financing
globenewswire.com - February 27 at 8:00 AM
marketbeat.com logoFederated Hermes Inc. Has $27.89 Million Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
marketbeat.com - February 24 at 7:49 AM
markets.businessinsider.com logoBuy Rating on Denali Therapeutics: Anticipating Accelerated FDA Approval with CSF HS Biomarker Breakthrough
markets.businessinsider.com - February 23 at 4:01 PM
markets.businessinsider.com logoBuy Rating Affirmed for Denali Therapeutics Amid Favorable Biomarker-Based Approval Prospects
markets.businessinsider.com - February 22 at 12:48 PM
marketbeat.com logoDenali Therapeutics (NASDAQ:DNLI) Receives "Buy" Rating from HC Wainwright
marketbeat.com - February 22 at 8:26 AM
marketbeat.com logoCitigroup Inc. Grows Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
marketbeat.com - February 22 at 5:24 AM
marketbeat.com logoDenali Therapeutics Inc. (NASDAQ:DNLI) Given Average Recommendation of "Buy" by Brokerages
marketbeat.com - February 20 at 1:36 AM
realmoney.thestreet.com logoDenali Therapeutics price target lowered by $5 at Citi, here's why
realmoney.thestreet.com - February 17 at 10:35 AM
finance.yahoo.com logoDNLI Mar 2024 12.500 call
finance.yahoo.com - February 16 at 11:24 PM
finance.yahoo.com logoDNLI Mar 2024 25.000 put
finance.yahoo.com - February 16 at 11:24 PM
markets.businessinsider.com logoMaintaining Buy on Denali Therapeutics: A Resilient Pipeline Despite Setbacks Offers Favorable Risk-Reward
markets.businessinsider.com - February 16 at 11:24 PM
Get Denali Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter.

Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

DNLI Media Mentions By Week

DNLI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DNLI
News Sentiment

0.27

0.38

Average
Medical
News Sentiment

DNLI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DNLI Articles
This Week

4

3

DNLI Articles
Average Week

Get Denali Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:DNLI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners